Study guide
Section 3.6: Saudi Pharmacy Law & SFDA Regulations
Saudi Pharmacist Licensure Examination SPLE - Pharmacist
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
Section 0.1: About the Saudi Pharmacist Licensure Examination (SPLE) Section 0.2: How to Study and Prep for the SPLE
2 Chapter 1: Basic Biomedical Sciences
Section 1.1: Human Physiology & Pathophysiology Foundations Section 1.2: Medical Biochemistry & Enzymology Section 1.3: Medical Microbiology & Immunology Section 1.4: Molecular Genetics & Pharmacogenomics Foundations
3 Chapter 2: Pharmaceutical Sciences
Section 2.1: Medicinal Chemistry & Structure-Activity Relationships (SAR) Section 2.2: Drug ADME (Absorption, Distribution, Metabolism, Excretion) Section 2.3: General Pharmacology: Mechanisms of Drug Action Section 2.4: General Toxicology: Overdose, Antidotes & Adverse Drug Reactions (ADRs) Section 2.5: Pharmacognosy: Natural Products & Dietary Supplements Section 2.6: Basic Pharmaceutics & Dosage Form Design Section 2.7: Biopharmaceutics & Drug Delivery Systems Section 2.8: Applied Pharmacokinetics (PK): One-Compartment Models Section 2.9: Non-linear and Multi-compartment Pharmacokinetics Section 2.10: Sterile Compounding: Techniques & Quality Standards Section 2.11: Non-sterile Compounding & Product Formulation Section 2.12: Pharmaceutical Calculations: Dosing and Strengths Section 2.13: Pharmaceutical Calculations: Dilutions and Reconstitution Section 2.14: Pharmaceutical Calculations: Osmolarity, Milliequivalents, and Alligations
4 Chapter 3: Social, Behavioral, and Administrative Sciences
Section 3.1: Saudi Arabian Healthcare System & Public Health Policies Section 3.2: Pharmacoepidemiology & Post-Marketing Drug Surveillance Section 3.3: Pharmacovigilance & Drug Safety Monitoring in Saudi Arabia Section 3.4: Pharmacoeconomic Principles & Cost-Benefit Analysis Section 3.5: Pharmacy Management, Inventory, and Operations Section 3.6: Saudi Pharmacy Law & SFDA Regulations Section 3.7: Biostatistics, Clinical Trial Design & Literature Evaluation Section 3.8: Professional Ethics, Communication, and Dispensing Systems
5 Chapter 4: Clinical Sciences
Section 4.1: Drug Information Services & Evidence-Based Medicine Section 4.2: Clinical Pharmacokinetics & Therapeutic Drug Monitoring (TDM) Section 4.3: Clinical Pharmacogenomics & Personalized Therapeutics Section 4.4: Disease Prevention, Wellness, and Immunization Schedules Section 4.5: Patient Assessment & Physical Examination Interpretation Section 4.6: Clinical Pharmacology: Cardiovascular Disorders Section 4.7: Clinical Pharmacology: Renal & Urological Disorders Section 4.8: Clinical Pharmacology: Respiratory & Pulmonary Disorders Section 4.9: Clinical Pharmacology: Endocrine & Metabolic Disorders Section 4.10: Clinical Pharmacology: Infectious Diseases & Antimicrobial Stewardship Section 4.11: Clinical Pharmacology: Neurological & Psychiatric Disorders Section 4.12: Clinical Pharmacology: Oncology, Immunology, and Hematology Section 4.13: Clinical Pharmacology: Gastrointestinal & Hepatic Disorders Section 4.14: Therapeutic Decision-Making in Special Populations (Geriatrics, Pediatrics, Pregnancy, Lactation)
Section 3.6: Saudi Pharmacy Law & SFDA Regulations
Key Takeaways Explain This Topic AI
No pharmaceutical product can be distributed in Saudi Arabia without registration, safety evaluation, and pricing approval by the SFDA.
Controlled substances are split into narcotics and psychotropics, requiring specialized duplicate/triplicate colored prescriptions.
Narcotic prescriptions must be filled within 3 days (72 hours) of issue and carry a maximum 30-day supply for chronic conditions.
Physicians must prescribe drugs by their scientific (generic) names, allowing pharmacists generic substitution within SFDA guidelines.
The Saudi Commission for Health Specialties (SCFHS) oversees licensing, professional exams (SPLE), and continuing education.
Last updated: July 2026
- Saudi Pharmacy Law & SFDA Regulations
- The Regulatory Framework of the SFDA
The Saudi Food and Drug Authority (SFDA) regulates the safety, quality, efficacy, and pricing of drugs, medical devices, food, and cosmetics within the Kingdom of Saudi Arabia. No pharmaceutical product can be imported, manufactured, or distributed in Saudi Arabia without being registered and approved by the SFDA.
Drug Registration Pathways : The SFDA categorizes drug registration into distinct files, including innovative products (new chemical entities), generics, biosimilars, and herbal products.
Pricing Mandate : The SFDA strictly regulates the public and private sector pricing of all registered medications, setting a fixed retail price (Public Selling Price - PSP) that must be displayed on the product packaging.
Controlled Drug Regulations in Saudi Arabia
The regulation of controlled substances in Saudi Arabia is governed by strict laws aimed at preventing addiction, diversion, and misuse while ensuring therapeutic availability. Controlled drugs are classified into distinct schedules based on their potential for abuse and therapeutic utility. Pharmacists must be familiar with the Law of Combatting Narcotics and Psychotropic Substances .
Narcotics, Psychotropics, and Semi-Controlled Substances
These substances are subject to the highest level of security, documentation, and specific record-keeping requirements:
Prescribing Authority : Controlled substances can only be prescribed by registered physicians with specialized licenses (consultants or specialists) within their scope of practice.
Controlled Prescription Forms : Prescriptions for narcotics and psychotropics must be written on specialized, serial-numbered, duplicate/triplicate colored prescription forms (traditionally pink for narcotics) or verified electronic equivalents. The pharmacist must file the copy and log it in the pharmacy's official controlled substance ledger.
Required Data Fields : The prescription must contain the patient's full name, National ID or Iqama (residence permit) number, age, diagnosis, drug name (scientific/generic name), strength, dosage form, instructions, quantity in digits and words, prescriber stamp, and signature.
Semi-Controlled Substances : Medications like pregabalin and gabapentin are classified as semi-controlled in Saudi Arabia due to their high local potential for misuse. They require standard prescription forms, but are tracked with mandatory documentation of the patient's national ID and cannot be refilled without a new medical order.
Validity & Quantity Limits :
Narcotic Prescriptions : Valid for only 3 days (72 hours) from the date of issue. The maximum supply limit is 30 days for chronic pain conditions (managed by oncology or palliative care) and 3 days for acute pain.
Psychotropic Prescriptions : Valid for 7 days from the date of issue. The maximum supply limit is typically 30 days for chronic conditions.
Disposal of Controlled Substances : The disposal of expired or damaged controlled drugs requires strict coordination. It must be conducted in the presence of an MOH representative and a designated pharmacist-in-charge as witnesses, with formal signatures on a destruction log to prevent diversion.
Prescription Validation and Dispensing
Pharmacists bear the legal responsibility to validate all prescriptions before dispensing:
Refills : Refills are prohibited for narcotics and psychotropic prescriptions. Chronic medications (non-controlled) can have refill schedules clearly documented by the physician, up to a maximum of one year.
Scientific/Generic Name Prescribing : Saudi law mandates that physicians prescribe medications by their scientific (generic) name. Pharmacists may perform generic substitution if the brand prescribed is unavailable, provided the patient is informed and the product has equivalent SFDA registration and therapeutic equivalence.
Tele-pharmacy and E-prescribing : Electronic prescriptions issued via approved Ministry of Health platforms (such as Sehhaty or Wasfaty) must be verified through two-factor authentication and are subject to the same validation laws as physical prescriptions.
Pharmacy and Pharmacist Licensing
Pharmacy operations and professional practice are governed by licensing standards set by both the MOH and the Saudi Commission for Health Specialties (SCFHS) :
Pharmacy Licensing : Community and hospital pharmacies must obtain operational licenses from the MOH and comply with SFDA regulations regarding storage temperatures (e.g., 2–8°C for refrigerators, 15–25°C for room temperature), security for controlled cabinets (including heavy-gauge dual-lock safes connected to central hospital alarm systems), and clean room standards. Violations of these pharmacy practice laws can result in severe administrative penalties, including fines up to 100,000 SAR, suspension, or license revocation.
Pharmacist Licensing : To practice pharmacy in Saudi Arabia, graduates must pass the Saudi Pharmacist Licensure Examination (SPLE) . Upon passing, they are registered and classified by the SCFHS.
Licensing Renewal : To maintain registration, pharmacists must complete a mandated number of Continuous Professional Development (CPD) hours (usually 20 hours per year) and show no history of ethical violations.
Summary of Saudi Controlled Prescription Rules
- Parameter Narcotic Drugs Psychotropic Drugs Semi-Controlled / G-Prescription
- Form Type Serialized Colored Form Serialized Colored Form Standard Prescription Form
- Prescription Validity 3 days (72 hours) 7 days 30 days
- Maximum Supply (Chronic) 30 days (requires oncology/specialist) 30 days 90 days
- Maximum Supply (Acute) 3 days 7-10 days Clinically indicated
- Refills Strictly Prohibited Strictly Prohibited Allowed if indicated
- Identification Required National ID / Iqama National ID / Iqama Recommended